Abstract Library
Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
ENETS Abstract Search
#4473 Somatostatin analogue delayed the recrudescence of stomach NET: A real-world study
Introduction: Type 1 gastric NENs (g-NENs) are common and relapse easily. Somstostatin analogues (SSAs) can inhibit gastrin secretion and cell proliferation. While the usage of SSAs in g-NENs is still controversial.
Conference:
Presenting Author: Cai W
Authors: Cai W, Zhang J, Ge W, Hu H,
Keywords: somatostatin analogue, Type 1 gastric NEN, real-world study,
Introduction: Gastric neuroendocrine neoplasms (G-NENs), as rare tumours, continue to increase in morbidity and mortality. The specificity of the clinical features of G-NENs has led to a lack of awareness of this disease.
Conference:
Presenting Author:
Keywords: Gastric neuroendocrine neoplasm, Clinicopathologic features, Prognosis,
Introduction: Endoscopic resection margin R1 (ER1) describes neoplasia presence at lateral and/or deep margin. Highest rate of R1 resection occurs in duodenal NENs (d-NENs) where advanced resection techniques [endoscopic submucosal dissection (ESD); full thickness resection (EFTR)], are more difficult to apply. In gastric (g-NENs) and rectal NENs (r-NENs), due to favourable anatomy, ESD or EFTR obtain lower rates of R1 resection.
Conference:
Presenting Author: Marasco M
Authors: Marasco M, Massironi S, Campana D, Mosca M, Dell'unto E,
Keywords: neuroendocrine, endoscopy,
#3762 Cabozantinib in high grade neuroendocrine neoplasms – Interim results from a Phase II trial
Introduction: Patients with high grade neuroendocrine neoplasms (HG-NENs) have limited treatment options. Cabozantinib, a multi kinase inhibitor can affect tumor growth and metastasis.
Conference:
Presenting Author: Trikalinos N
Authors: Trikalinos N, Pedersen K, Tan B, Amin M, Rama S,
Keywords: Cabozantinib, high-grade, neuroendocrine, neoplasm, clinical trial,
Introduction: The optimal endoscopic management for Gastric Neuroendocrine Neoplasms (G-NENs) is yet to be determined, and data are limited in the literature.
Conference:
Presenting Author: Lazaridis N
Authors: Lazaridis N, Despott E, Chacchi-Cahuin R, Lemmers A, Rimondi A,